5-[4-(3,5-dimethyl-1H-pyrazol-4-yl)-2-methoxyphenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine;N-methyl-5-[4-(1-methylpyrazol-4-yl)-2-(trifluoromethyl)phenyl]-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine;5-(1-methylpyrazol-4-yl)-2-[5-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,4-thiadiazol-2-yl]phenol;2-[5-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,4-thiadiazol-2-yl]-5-pyrazol-1-ylphenol
C90H121F3N24O3S4 — CID 158070912
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[4-(3,5-dimethyl-1H-pyrazol-4-yl)-2-methoxyphenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine;N-methyl-5-[4-(1-methylpyrazol-4-yl)-2-(trifluoromethyl)phenyl]-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine;5-(1-methylpyrazol-4-yl)-2-[5-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,4-thiadiazol-2-yl]phenol;2-[5-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,4-thiadiazol-2-yl]-5-pyrazol-1-ylphenol
5-[4-(3,5-dimethyl-1H-pyrazol-4-yl)-2-methoxyphenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine;N-methyl-5-[4-(1-methylpyrazol-4-yl)-2-(trifluoromethyl)phenyl]-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine;5-(1-methylpyrazol-4-yl)-2-[5-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,4-thiadiazol-2-yl]phenol;2-[5-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,4-thiadiazol-2-yl]-5-pyrazol-1-ylphenol (PubChem CID 158070912) has the molecular formula C90H121F3N24O3S4 and a molecular weight of 1772.38 g/mol. Its IUPAC name is 5-[4-(3,5-dimethyl-1H-pyrazol-4-yl)-2-methoxyphenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine;N-methyl-5-[4-(1-methylpyrazol-4-yl)-2-(trifluoromethyl)phenyl]-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine;5-(1-methylpyrazol-4-yl)-2-[5-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,4-thiadiazol-2-yl]phenol;2-[5-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,4-thiadiazol-2-yl]-5-pyrazol-1-ylphenol.
Molecular Properties
| Compound Name | 5-[4-(3,5-dimethyl-1H-pyrazol-4-yl)-2-methoxyphenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine;N-methyl-5-[4-(1-methylpyrazol-4-yl)-2-(trifluoromethyl)phenyl]-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine;5-(1-methylpyrazol-4-yl)-2-[5-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,4-thiadiazol-2-yl]phenol;2-[5-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,4-thiadiazol-2-yl]-5-pyrazol-1-ylphenol |
|---|---|
| PubChem CID | 158070912 |
| Molecular Formula | C90H121F3N24O3S4 |
| Molecular Weight | 1772.38 g/mol |
| Exact Mass | 1770.89 |
| IUPAC Name | 5-[4-(3,5-dimethyl-1H-pyrazol-4-yl)-2-methoxyphenyl]-N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine;N-methyl-5-[4-(1-methylpyrazol-4-yl)-2-(trifluoromethyl)phenyl]-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,4-thiadiazol-2-amine;5-(1-methylpyrazol-4-yl)-2-[5-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,4-thiadiazol-2-yl]phenol;2-[5-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,4-thiadiazol-2-yl]-5-pyrazol-1-ylphenol |
| SMILES | CN(c1nnc(-c2ccc(-c3cnn(C)c3)cc2C(F)(F)F)s1)C1CC(C)(C)NC(C)(C)C1.CN(c1nnc(-c2ccc(-c3cnn(C)c3)cc2O)s1)C1CC(C)(C)NC(C)(C)C1.CN(c1nnc(-c2ccc(-n3cccn3)cc2O)s1)C1CC(C)(C)NC(C)(C)C1.COc1cc(-c2c(C)n[nH]c2C)ccc1-c1nnc(N(C)C2CC(C)(C)NC(C)(C)C2)s1 |
| InChI | InChI=1S/C24H34N6OS.C23H29F3N6S.C22H30N6OS.C21H28N6OS/c1-14-20(15(2)26-25-14)16-9-10-18(19(11-16)31-8)21-27-28-22(32-21)30(7)17-12-23(3,4)29-24(5,6)13-17;1-21(2)10-16(11-22(3,4)30-21)32(6)20-29-28-19(33-20)17-8-7-14(9-18(17)23(24,25)26)15-12-27-31(5)13-15;1-21(2)10-16(11-22(3,4)26-21)28(6)20-25-24-19(30-20)17-8-7-14(9-18(17)29)15-12-23-27(5)13-15;1-20(2)12-15(13-21(3,4)25-20)26(5)19-24-23-18(29-19)16-8-7-14(11-17(16)28)27-10-6-9-22-27/h9-11,17,29H,12-13H2,1-8H3,(H,25,26);7-9,12-13,16,30H,10-11H2,1-6H3;7-9,12-13,16,26,29H,10-11H2,1-6H3;6-11,15,25,28H,12-13H2,1-5H3 |
| InChIKey | FLUQTYATBKXIEN-UHFFFAOYSA-N |
| XLogP | 18.23 |
| TPSA | 296.03 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 124 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1772.38 |
| LogP ≤ 5 | 18.23 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 30 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158070912 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.